These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6268553)

  • 1. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
    Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
    Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
    Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
    Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
    Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
    Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-barr virus VCA IgM and EBNA IgG antibodies titered by immunofluorescence in microplates. A semi-automated method based on microtiter system.
    Lamy ME; Favart AM; Leclercq MF; Segas M; Mendez M; Lhoir C; Cornu C; Burtonboy G
    Med Microbiol Immunol; 1982; 170(4):247-53. PubMed ID: 6285158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
    Gong SH; Lynn TC; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):8-15. PubMed ID: 211015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
    Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
    APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma.
    Chan CK; Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
    Cancer Causes Control; 1991 Mar; 2(2):125-31. PubMed ID: 1651778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.
    Morinet F; Icart J; Ruelle C; Gluckman E; Perol Y
    J Med Virol; 1986 Apr; 18(4):349-60. PubMed ID: 3011981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions.
    Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H
    Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated IgA antibodies to Epstein-Barr virus in children with chronic active Epstein-Barr virus infection.
    Wakiguchi H; Fujieda M; Kubota H; Matsumoto K; Wakiguchi A; Kurashige T; Oda M
    Acta Med Okayama; 1989 Jun; 43(3):193-6. PubMed ID: 2548373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous reactivation of Epstein-Barr virus infections.
    Sumaya CV
    J Infect Dis; 1977 Mar; 135(3):374-9. PubMed ID: 191540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.